- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/13 - Amines, p. ex. amantadine
Détention brevets de la classe A61K 31/13
Brevets de cette classe: 1645
Historique des publications depuis 10 ans
106
|
109
|
103
|
114
|
104
|
84
|
85
|
87
|
157
|
119
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
The Regents of the University of California | 20087 |
30 |
Adamas Pharma, LLC | 49 |
27 |
MERZ PHARMA GmbH & CO. KGaA | 609 |
22 |
The General Hospital Corporation | 4771 |
21 |
Suven Life Sciences Limited | 135 |
18 |
Adamas Pharmaceuticals, Inc. | 22 |
14 |
Anavex Life Sciences Corp. | 71 |
13 |
The Board of Trustees of the Leland Stanford Junior University | 6462 |
12 |
Corium, LLC | 42 |
11 |
University of Florida Research Foundation, Inc. | 4048 |
10 |
Dana-Farber Cancer Institute, Inc. | 2593 |
10 |
Indiana University Research and Technology Corporation | 801 |
10 |
Ovid Therapeutics Inc | 167 |
10 |
Aldeyra Therapeutics, Inc. | 110 |
9 |
Targacept, Inc. | 56 |
9 |
The Trustees of Columbia University in the City of New York | 3589 |
8 |
Helsinn Birex Pharmaceuticals Ltd | 11 |
8 |
IntraBio Ltd | 52 |
8 |
The Trustees of the University of Pennsylvania | 4342 |
7 |
Board of Supervisors of Louisiana State University and Agricultural and Mechanical College | 823 |
7 |
Autres propriétaires | 1381 |